A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

NCT00190697 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Endometrial Cancer
Ovarian Cancer

Interventions

DRUG: arzoxifene

Sponsor

Eli Lilly and Company